MiR-150 and miR-155 expression predicts survival of cervical cancer patients: a translational approach to novel prognostic biomarkers

References

• Araújo R, Santos JMO, Fernandes M, Dias F, Sousa H, Ribeiro J, Bastos MMSM, Oliveira PA, Carmo D, Casaca F, et al. 2018. Expression profile of microRNA-146a along HPV-induced multistep carcinogenesis: a study in HPV16 transgenic mice. J Cancer Res Clin Oncol. 144(2):241–248. doi: 10.1007/s00432-017-2549-5
   PubMed Web of Science ®Google Scholar
• Arbeit JM, Munger K, Howley PM, Hanahan D. 1994. Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J Virol. 68(7):4358–4368. doi: 10.1128/JVI.68.7.4358-4368.1994
   PubMed Web of Science ®Google Scholar
• Bonneau E, Neveu B, Kostantin E, et al. 2019. How close are miRNAs from clinical practice? A perspective on the diagnostic and therapeutic market. Ejifcc. 30:114–127.
   PubMedGoogle Scholar
• Bzhalava D, Guan P, Franceschi S, Dillner J, Clifford G. 2013. A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types. Virology. 445(1-2):224–231. doi: 10.1016/j.virol.2013.07.015
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research, et al. 2017. Integrated genomic and molecular characterization of cervical cancer. Nature. 543:378–384.
   PubMed Web of Science ®Google Scholar
• Chang H-Y, Lee C-H, Li Y-S, Huang J-T, Lan S-H, Wang Y-F, Lai W-W, Wang Y-C, Lin Y-J, Liu H-S, et al. 2020. MicroRNA-146a suppresses tumor malignancy via targeting vimentin in esophageal squamous cell carcinoma cells with lower fibronectin membrane assembly. J Biomed Sci. 27(1):102. doi: 10.1186/s12929-020-00693-4
   PubMed Web of Science ®Google Scholar
• Chen G, Umelo IA, Lv S, Teugels E, Fostier K, Kronenberger P, Dewaele A, Sadones J, Geers C, De Grève J, et al. 2013. miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells. PLoS One. 8(3):e60317. doi: 10.1371/journal.pone.0060317
   PubMed Web of Science ®Google Scholar
• Chen X, Xu X, Pan B, Zeng K, Xu M, Liu X, He B, Pan Y, Sun H, Wang S, et al. 2018. miR-150-5p suppresses tumor progression by targeting VEGFA in colorectal cancer. Aging (Albany Ny)). 10(11):3421–3437. doi: 10.18632/aging.101656
   PubMedGoogle Scholar
• Contreras J, Rao DS. 2012. MicroRNAs in inflammation and immune responses. Leukemia. 26(3):404–413. doi: 10.1038/leu.2011.356
   PubMed Web of Science ®Google Scholar
• Costa AC, Santos JMO, Medeiros-Fonseca B, Oliveira PA, Bastos MMSM, Brito HO, Gil da Costa RM, Medeiros R. 2022. Characterizing the inflammatory microenvironment in K14-HPV16 transgenic mice: mast cell infiltration and MicroRNA expression. Cancers (Basel). 14(9):2216. doi: 10.3390/cancers14092216
   PubMed Web of Science ®Google Scholar
• Cui F, Li X, Zhu X, Huang L, Huang Y, Mao C, Yan Q, Zhu J, Zhao W, Shi H, et al. 2012. MiR-125b inhibits tumor growth and promotes apoptosis of cervical cancer cells by targeting phosphoinositide 3-kinase catalytic subunit delta. Cell Physiol Biochem. 30(5):1310–1318. doi: 10.1159/000343320
   PubMedGoogle Scholar
• de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. 2020. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 8(2):e180–e190. doi: 10.1016/S2214-109X(19)30488-7
   PubMed Web of Science ®Google Scholar
• de Villiers E-M, Fauquet C, Broker TR, Bernard H-U, Zur Hausen H. 2004. Classification of papillomaviruses. Virology. 324(1):17–27. doi: 10.1016/j.virol.2004.03.033
   PubMed Web of Science ®Google Scholar
• Doghish AS, Ali MA, Elyan SS, Elrebehy MA, Mohamed HH, Mansour RM, Elgohary A, Ghanem A, Faraag AHI, Abdelmaksoud NM, et al. 2023. miRNAs role in cervical cancer pathogenesis and targeted therapy: Signaling pathways interplay. Pathol Res Pract. 244:154386. doi: 10.1016/j.prp.2023.154386
   PubMed Web of Science ®Google Scholar
• Dong Z, Yu C, Rezhiya K, Gulijiahan A, Wang X. 2019. Downregulation of miR-146a promotes tumorigenesis of cervical cancer stem cells via VEGF/CDC42/PAK1 signaling pathway. Artif Cells Nanomed Biotechnol. 47(1):3711–3719. doi: 10.1080/21691401.2019.1664560
   PubMed Web of Science ®Google Scholar
• Estevao D, Costa NR, Gil da Costa RM, Medeiros R. 2019. Hallmarks of HPV carcinogenesis: The role of E6, E7 and E5 oncoproteins in cellular malignancy. Biochim Biophys Acta Gene Regul Mech. 1862(2):153–162. doi: 10.1016/j.bbagrm.2019.01.001
   PubMed Web of Science ®Google Scholar
• Fang H, Shuang D, Yi Z, Sheng H, Liu Y. 2016. Up-regulated microRNA-155 expression is associated with poor prognosis in cervical cancer patients. Biomed Pharmacother. 83:64–69. doi: 10.1016/j.biopha.2016.06.006
   PubMed Web of Science ®Google Scholar
• Fu K, Zhang L, Liu R, Shi Q, Li X, Wang M. 2020. MiR-125 inhibited cervical cancer progression by regulating VEGF and PI3K/AKT signaling pathway. World J Surg Oncol. 18(1):115. doi: 10.1186/s12957-020-01881-0
   PubMed Web of Science ®Google Scholar
• Gil da Costa RM, Medeiros R. 2014. Bovine papillomavirus: opening new trends for comparative pathology. Arch Virol. 159(2):191–198. doi: 10.1007/s00705-013-1801-9
   PubMed Web of Science ®Google Scholar
• Gocze K, Gombos K, Kovacs K, et al. 2015. MicroRNA expressions in HPV-induced cervical dysplasia and cancer. Anticancer Res. 35:523–530.
   PubMed Web of Science ®Google Scholar
• Hu G, Wang S, Cheng P. 2018. Tumor-infiltrating tryptase(+) mast cells predict unfavorable clinical outcome in solid tumors. Int J Cancer. 142(4):813–821. doi: 10.1002/ijc.31099
   PubMed Web of Science ®Google Scholar
• Jabbar S, Strati K, Shin MK, Pitot HC, Lambert PF. 2010. Human papillomavirus type 16 E6 and E7 oncoproteins act synergistically to cause head and neck cancer in mice. Virology. 407(1):60–67. doi: 10.1016/j.virol.2010.08.003
   PubMed Web of Science ®Google Scholar
• Keser SH, Kandemir NO, Ece D, Gecmen GG, Gul AE, Barisik NO, Sensu S, Buyukuysal C, Barut F. 2017. Relationship of mast cell density with lymphangiogenesis and prognostic parameters in breast carcinoma. Kaohsiung J Med Sci. 33(4):171–180. doi: 10.1016/j.kjms.2017.01.005
   PubMed Web of Science ®Google Scholar
• Lao G, Liu P, Wu Q, Zhang W, Liu Y, Yang L, Ma C. 2014. Mir-155 promotes cervical cancer cell proliferation through suppression of its target gene LKB1. Tumour Biol. 35(12):11933–11938. doi: 10.1007/s13277-014-2479-7
   PubMedGoogle Scholar
• Li J, Hu L, Tian C, et al. 2015. microRNA-150 promotes cervical cancer cell growth and survival by targeting FOXO4. BMC Mol Biol. 16:24.
   PubMed Web of Science ®Google Scholar
• Li T, Li M, Xu C, et al. 2019. miR146a regulates the function of Th17 cell differentiation to modulate cervical cancer cell growth and apoptosis through NFkappaB signaling by targeting TRAF6. Oncol Rep. 41:2897–2908.
   PubMed Web of Science ®Google Scholar
• Li N, Cui T, Guo W, Wang D, Mao L. 2019. MiR-155-5p accelerates the metastasis of cervical cancer cell via targeting TP53INP1. Onco Targets Ther. 12:3181–3196. doi: 10.2147/OTT.S193097
   PubMed Web of Science ®Google Scholar
• Liu DK, Yu S, Li JP, et al. 2021. MiR-150 suppressed cell viability, invasion and EMT via HMGA2 in oral squamous cell carcinoma. Eur Rev Med Pharmacol Sci. 25:3981–3989.
   PubMed Web of Science ®Google Scholar
• Lu W, Zhang H, Niu Y, Wu Y, Sun W, Li H, Kong J, Ding K, Shen H-M, Wu H, et al. 2017. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p. Mol Cancer. 16(1):118. doi: 10.1186/s12943-017-0685-9
   PubMed Web of Science ®Google Scholar
• Medeiros-Fonseca B, Mestre VF, Estêvão D, Sánchez DF, Cañete-Portillo S, Fernández-Nestosa MJ, Casaca F, Silva S, Brito H, Félix A, et al. 2020. HPV16 induces penile intraepithelial neoplasia and squamous cell carcinoma in transgenic mice: first mouse model for HPV-related penile cancer. J Pathol. 251(4):411–419. doi: 10.1002/path.5475
   PubMed Web of Science ®Google Scholar
• Mestre VF, Medeiros-Fonseca B, Estêvão D, Casaca F, Silva S, Félix A, Silva F, Colaço B, Seixas F, Bastos MM, et al. 2020. HPV16 is sufficient to induce squamous cell carcinoma specifically in the tongue base in transgenic mice. J Pathol. 251(1):4–11. doi: 10.1002/path.5387
   PubMed Web of Science ®Google Scholar
• Musilova K, Devan J, Cerna K, Seda V, Pavlasova G, Sharma S, Oppelt J, Pytlik R, Prochazka V, Prouzova Z, et al. 2018. miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels. Blood. 132(22):2389–2400. doi: 10.1182/blood-2018-06-855502
   PubMed Web of Science ®Google Scholar
• Paiva I, Gil da Costa RM, Ribeiro J, Sousa H, Bastos M, Faustino-Rocha A, Lopes C, Oliveira PA, Medeiros R. 2015. A role for microRNA-155 expression in microenvironment associated to HPV-induced carcinogenesis in K14-HPV16 transgenic mice. PLoS One. 10(1):e0116868. doi: 10.1371/journal.pone.0116868
   PubMed Web of Science ®Google Scholar
• Paiva I, Gil da Costa RM, Ribeiro J, Sousa H, Bastos MMSM, Faustino-Rocha A, Lopes C, Oliveira PA, Medeiros R. 2015. MicroRNA-21 expression and susceptibility to HPV-induced carcinogenesis - role of microenvironment in K14-HPV16 mice model. Life Sci. 128:8–14. doi: 10.1016/j.lfs.2015.02.020
   PubMed Web of Science ®Google Scholar
• Raica M, Cimpean AM, Ceausu R, et al. 2013. Interplay between mast cells and lymphatic vessels in different molecular types of breast cancer. Anticancer Res. 33:957–963.
   PubMed Web of Science ®Google Scholar
• Ribeiro J, Marinho-Dias J, Monteiro P, Loureiro J, Baldaque I, Medeiros R, Sousa H. 2015. miR-34a and miR-125b expression in HPV infection and cervical cancer development. Biomed Res Int. 2015:304584–304586. doi: 10.1155/2015/304584
   PubMed Web of Science ®Google Scholar
• Santos JMO, Gil da Costa RM, Medeiros R. 2018. Dysregulation of cellular microRNAs by human oncogenic viruses - Implications for tumorigenesis. Biochim Biophys Acta Gene Regul Mech. 1861(2):95–105. doi: 10.1016/j.bbagrm.2018.01.017
   PubMed Web of Science ®Google Scholar
• Santos JMO, Fernandes M, Araújo R, Sousa H, Ribeiro J, Bastos MMSM, Oliveira PA, Carmo D, Casaca F, Silva S, et al. 2017. Dysregulated expression of microRNA-150 in human papillomavirus-induced lesions of K14-HPV16 transgenic mice. Life Sci. 175:31–36. doi: 10.1016/j.lfs.2017.03.008
   PubMed Web of Science ®Google Scholar
• Santos JMO, Peixoto da Silva S, Bastos MMSM, Oliveira PA, Gil da Costa RM, Medeiros R. 2022. Decoding the role of inflammation-related microRNAs in cancer cachexia: a study using HPV16-transgenic mice and in silico approaches. J Physiol Biochem. 78(2):439–455. doi: 10.1007/s13105-021-00866-1
   PubMed Web of Science ®Google Scholar
• Sarver AL, Sarver AE, Yuan C, Subramanian S. 2018. OMCD: OncomiR Cancer Database. BMC Cancer. 18(1):1223. doi: 10.1186/s12885-018-5085-z
   PubMedGoogle Scholar
• Smith-McCune K, Zhu YH, Hanahan D, Arbeit J. 1997. Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice. Cancer Res. 57(7):1294–1300.
   PubMed Web of Science ®Google Scholar
• Spurgeon ME, den Boon JA, Horswill M, et al. 2017. Human papillomavirus oncogenes reprogram the cervical cancer microenvironment independently of and synergistically with estrogen. Proc Natl Acad Sci U S A. 114:E9076–E9085.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 71(3):209–249. doi: 10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Thomas MK, Pitot HC, Liem A, Lambert PF. 2011. Dominant role of HPV16 E7 in anal carcinogenesis. Virology. 421(2):114–118. doi: 10.1016/j.virol.2011.09.018
   PubMed Web of Science ®Google Scholar
• Trigo G, Dinis M, França Â, Bonifácio Andrade E, Gil da Costa RM, Ferreira P, Tavares D. 2009. Leukocyte populations and cytokine expression in the mammary gland in a mouse model of Streptococcus agalactiae mastitis. J Med Microbiol. 58(Pt 7):951–958. doi: 10.1099/jmm.0.007385-0
   PubMed Web of Science ®Google Scholar
• Wang X, Kan Y, Chen L, Ge P, Ding T, Zhai Q, Yu Y, Wang X, Zhao Z, Yang H, et al. 2020. miR-150 is a negative independent prognostic biomarker for primary gastrointestinal diffuse large B-cell lymphoma. Oncol Lett. 19(5):3487–3494. doi: 10.3892/ol.2020.11452
   PubMed Web of Science ®Google Scholar
• Wilczynski M, Zytko E, Szymanska B, et al. 2017. Expression of miR-146a in patients with ovarian cancer and its clinical significance. Oncol Lett. 14:3207–3214.
   PubMedGoogle Scholar
• Wu C, Cao Y, He Z, He J, Hu C, Duan H, Jiang J. 2014. Serum levels of miR-19b and miR-146a as prognostic biomarkers for non-small cell lung cancer. Tohoku J Exp Med. 232(2):85–95. doi: 10.1620/tjem.232.85
   PubMed Web of Science ®Google Scholar
• Yang TJ, Wang L, Zhang Y, et al. 2020. LncRNA UCA1 regulates cervical cancer survival and EMT occurrence by targeting miR-155. Eur Rev Med Pharmacol Sci. 24:9869–9879.
   PubMed Web of Science ®Google Scholar
• Youden WJ. 1950. Index for rating diagnostic tests. Cancer. 3(1):32–35. doi: 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang J, Li J, Wang X, Song W. 2018. MicroRNA-150 promotes cell proliferation, migration, and invasion of cervical cancer through targeting PDCD4. Biomed Pharmacother. 97:511–517. doi: 10.1016/j.biopha.2017.09.143
   PubMed Web of Science ®Google Scholar